Inflammatory bowel disease (IBD) represents a disease that is characterized by chronic inflammation of the gastrointestinal tract. It usually tends to occur in the case of genetically susceptible individuals after an exaggerated immune response to a normal stimulus comprising intestinal flora and food. Some of the common symptoms include fatigue, abdominal pain, cramping, blood in the stool, diarrhea, reduced appetite and unintended weight loss, mouth sores, pain or drainage near and around the anus, etc. The diagnosis of IBD generally requires a combination of clinical and imaging findings, inflammatory laboratory markers, endoscopic biopsies, etc.Ask an Analyst for Report Customization with TOC & List of figures: [FURL=https://bit.ly/3UEwEs1]https://bit.ly/3UEwEs1[/FURL]
Market Trend:
The rising prevalence of gastrointestinal disorders, owing to numerous associated factors, such as environmental triggers, immune system disturbances, genetic predisposition, etc., is primarily driving the inflammatory bowel disease market. Additionally, the widespread adoption of diagnostic procedures, including serologic markers and comprehensive metabolic panels, for early diagnosis of the disease is further catalyzing the market growth.
Besides this, the increasing utilization of corticosteroids as the first line of treatment and their easy availability at retail pharmacy stores are acting as significant growth-inducing factors. Moreover, the inflating popularity of biologic and biosimilar drugs over traditional treatment options, on account of their enhanced efficacy, is positively influencing the global market.
Apart from this, the growing utilization of pre-biotic and pro-biotic food products to improve gut health and the development of novel therapies with a better clinical profile and a patient-friendly route of administration (RoA) are also stimulating the market growth. Furthermore, the escalating demand for single-cell RNA analysis to understand the molecular basis of the disease is anticipated to fuel the inflammatory bowel disease market over the forecasted period.
Request a Free Sample Report: [URL=https://www.imarcgroup.com/inflammatory-bowel-disease-market/requestsample]https://www.imarcgroup.com/inflammatory-bowel-disease-market/requestsample[/URL]
Key Questions Answered in this Report:
How has the inflammatory bowel disease market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the inflammatory bowel disease market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the inflammatory bowel disease market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800